Treatment effect with 2 photorefractive intrastromal cross-linking protocols in low-grade myopia through 24-month follow-up.

PiXL can reduce low-grade myopia and improve uncorrected vision in healthy eyes. The initial ocular discomfort may be reduced with an annular treatment zone. Further studies are needed to optimize PiXL treatment parameters.